Asuragen In Brief This Week: Bio-Techne, Dante Labs, Metagenomi, Applied DNA Sciences, Caris Life Sciences News items for the week of April 5, 2021. Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy Premium Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise. Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M Bio-Techne said Asuragen's headquarters in Austin, Texas includes a scalable 50,000-square-foot manufacturing facility and CLIA-certified laboratory. Pacific Biosciences, Asuragen Collaborate on Clinical Assays Asuragen will develop assays for PacBio's long-read next-generation sequencing systems, with an initial focus on developing a carrier screening assay. Asuragen Receives CE Mark for Spinal Muscular Atrophy Assay The test can help diagnose spinal muscular atrophy and identify carriers without symptoms who may be at risk of passing the disease to their children. Feb 23, 2020 Asuragen Fragile X Diagnostic Test Gets FDA Authorization Nov 25, 2019 Asuragen, Wave Life Sciences to Develop Companion Diagnostics for Huntington's Disease Therapies Dec 4, 2018 Asuragen Myotonic Dystrophy 1 Dx Kit Receives CE Mark Nov 13, 2018 Health Canada Approves Two BCR-ABL Tests Oct 22, 2018 Asuragen, RTI Collaborate on Fragile X Syndrome Testing Oct 19, 2018 People in the News: Mary Padbury, Katherine Bach Kalin, Daniel Kolk, More Sep 7, 2018 Asuragen ALS, Dementia Assay Gets Favorable Evaluation From UPenn Team Premium Sep 7, 2018 New Products Posted to GenomeWeb: Genoptix, Asuragen Sep 5, 2018 Asuragen Gets CE Mark for QuantideX NGS Oncology Panel Jul 27, 2018 New Products Posted to GenomeWeb: SeraCare, Asuragen, Biofortuna, More Jun 1, 2018 New Products Posted to GenomeWeb: PerkinElmer, Phase Genomics, Pacific Biosciences, Asuragen, More Jan 17, 2018 Asuragen Gets CE Mark for QuantideX BCR-ABL Kits on Roche Platform Feb 21, 2017 Asuragen to Develop IVD Kits on Thermo Fisher Scientific's CE Platform Dec 12, 2016 Asuragen Research Correlates FMR1 Methylation, Symptoms in Fragile X-Associated Motor Disorder Premium Jul 25, 2016 Asuragen BCR-ABL Kit Granted FDA Premarket Clearance May 19, 2016 Surgical Decisions for Thyroid Nodules Often Not Affected By Molecular Testing Sep 9, 2015 Illumina, Asuragen to Collaborate on Companion Diagnostics Development Jun 11, 2015 Asuragen BCR-ABL Assay Receives CE Mark Dec 10, 2014 Additional Members Join UK Cancer Consortium Dec 5, 2014 Study Shows FFPE Pre-PCR Processing Problems Plague Pathology Labs Premium Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.